Atrial Fibrillation

In this interview with JIC, Matthew Sherwood, MD, discusses how the 3-year results of the CHAMPION-AF trial support LAAC with the WATCHMAN FLX™ (Boston Scientific) as a safe, effective, and lower-bleeding alternative to long-term oral...

A 54-year-old man with coronary artery disease with multiple prior percutaneous coronary interventions, hypertension, paroxysmal atrial fibrillation on apixaban, hyperlipidemia, prior cerebrovascular accident with residual right-sided...

In this 2026 SCAI session, Dr Saibal Kar explored how LAAO is moving beyond its traditional use in patients with nonvalvular AFib who are ineligible for anticoagulation.

Subhasis Chatterjee, MD, and Stefano Schena, MD, PhD, discuss the STS’ 2026 Clinical Practice Guidelines for the Prevention and Treatment of New-Onset Postoperative AF After Cardiac Surgery.

At his CRT 2026 Keynote Lecture, Dr James L. Cox emphasized the importance of treating atrial fibrillation during cardiac surgery, underscoring that failure to do so significantly worsens long-term outcomes.

Dr Devi Nair's session at CRT 2026 reviewed the rapidly evolving landscape of next-generation left atrial appendage closure devices for stroke prevention in atrial fibrillation, emphasizing iterative improvements in plug and plication...

In this interview from CRT 2026, Dr Garima Wadhwani discusses her Top Abstract evaluating left atrial appendage occlusion as a safer alternative to oral anticoagulation for select atrial fibrillation patients with cirrhosis.

In this session from CRT 2026, Dr Nassir F. Marrouche of Tulane University presented the latest evidence positioning pulsed field ablation as a transformative advance in AF ablation.

In this CRT 2026 interview, Dr Andreas Sarantopoulos of the NCH Rooney Heart Institute discusses his Top Abstract on machine learning for predicting recurrent atrial fibrillation and its implications for interventional cardiology practice.

In his session at CRT 2026, Dr Eric Secemsky reviewed contemporary data linking sympathetic overactivity to heart failure, atrial fibrillation, and cardiometabolic disease, and examined how renal and multi-organ denervation may modify these...